Skip to content

Clinical trials

Completed Overweight trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Completed Country / region: Taiwan Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20141
20171
20185
20191
20201
20215
20221
20238
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S5
Eli Lilly and Company4
China Medical University Hospital2
Chung Shan Medical University2
Mackay Medical College2
National Taiwan University Hospital2
Amgen1
AstraZeneca1
Chang Gung Memorial Hospital1
Greenyn Biotechnology Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight27
Obesity22
Diabetes Mellitus, Type 25
Nutrition Disorders4
Metabolic Syndrome3
Prediabetic State2
Weight Loss2
Fatigue1
Gestational Weight Gain1
Hypercholesterolemia1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.